Внутренние болезни
948 статей · 31 журналов
Журналы подкатегории (31)
- Kidney Medicine · Elsevier (87)
- Canadian Journal of Diabetes · Elsevier (84)
- European Journal of Internal Medicine · Elsevier (84)
- International Journal of Cardiology Cardiovascular Risk and Prevention · Elsevier (80)
- JHEP Reports · Elsevier (80)
- Internal Medicine Journal · Wiley (73)
- Journal of Diabetes Investigation · Wiley (73)
- Diabetes Research and Clinical Practice · Elsevier (68)
- Médecine des Maladies Métaboliques · Elsevier (61)
- La Revue de Médecine Interne · Elsevier (58)
- The Lancet Diabetes & Endocrinology · Elsevier (45)
- Atherosclerosis Plus · Elsevier (42)
- American Journal of Medicine Open · Elsevier (31)
- Journal of Internal Medicine · Wiley (24)
- Journal of General and Family Medicine · Wiley (15)
- Journal of Diabetes and its Complications · Elsevier (13)
- Diabetes & Metabolic Syndrome: Clinical Research & Reviews · Elsevier (12)
- Nutrition Clinique et Métabolisme · Elsevier (10)
- Journal of Human Hypertension · Springer Nature (8)
- Current Diabetes Reports · Springer Nature (0)
- Current Hypertension Reports · Springer Nature (0)
- Current Obesity Reports · Springer Nature (0)
- Diabetes Therapy · Springer Nature (0)
- Diabetologia · Springer Nature (0)
- Diabetology International · Springer Nature (0)
- Internal and Emergency Medicine · Springer Nature (0)
- International Journal of Diabetes in Developing Countries · Springer Nature (0)
- Journal of General Internal Medicine · Springer Nature (0)
- Journal of Rare Diseases · Springer Nature (0)
- Journal of Ultrasound · Springer Nature (0)
- Medizinische Klinik - Intensivmedizin und Notfallmedizin · Springer Nature (0)
- Noncoding RNAs as novel diagnostic biomarkers for diabetic retinopathy: A systematic review and meta‐analysis
- A pitfall in the evaluation of Sampson‐estimated small dense LDL cholesterol in metabolic disorders: Is it equivalent to directly measured sdLDL‐C?
- Comment on “Influence of Age on the Development of Stress Hyperglycemia During First‐Onset ST‐Elevation Myocardial Infarction”
- Comment on “Physiological phenotypes of obstructive sleep apnea identified by cluster analysis: Association with type 2 diabetes”
- Clarifying frailty‐associated factors in type 2 diabetes and coronary heart disease
- Hepatic steatosis risk in nonobese Chinese adults with type 1 diabetes
- Issue Information
- Class effect beyond glucose: Implications of the LEGEND‐T2DM findings for cardiovascular outcomes
- Commentary on: Genetic predictors of GLP1 receptor agonist weight loss and side effects (Nature volume 653, pages 770–775 (2026))
- Circadian metabolic dysfunction in MASLD: Physiological insights and future directions
-
Changes in liver steatosis and liver stiffness following Empagliflozin treatment in patients with MASLD and type 2 diabetes: A single‐arm pre–post study
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) is common in subjects with type 2 diabetes mellitus (T2DM), being linked to a higher risk for the development of liver‐related and cardiovascular...
-
Long-term follow-up of adolescents with white coat hypertension: a preliminary exploratory study
Journal of Human Hypertension, Published online: 02 November 2026; doi:10.1038/s41371-026-01248-0 Long-term follow-up of adolescents with white coat hypertension: a preliminary exploratory study
-
Clinical utility of bronchoalveolar lavage in immunocompromised patients with pulmonary infiltrates: impact on diagnostic yield and management
Abstract Background Pulmonary infiltrates in immunocompromised patients are associated with high morbidity and mortality, and accurate diagnosis is often challenging due to overlapping infectious and non‐infectious aetiologies. Flexible...
-
Defining best practice for very old patients following unplanned intensive care admission: protocol of the Delphi consensus study
Abstract Background Very old patients (≥80 years) represent a rapidly increasing proportion of intensive care unit (ICU) admissions across Australia and New Zealand. Care of this population is characterised by substantial prognostic...
-
How should junior doctors navigate artificial intelligence clinical advice?
Abstract Artificial intelligence (AI) clinical decision support tools are becoming increasingly integrated into medical decision‐making, offering rapid, evidence‐based clinical recommendations. While surrounding discussion has largely...
- Late diagnosis in adults with inborn errors of immunity: the hypomorphic phenotype deserves explicit recognition
-
Cost‐effectiveness analysis comparing advanced hybrid closed‐loop automated insulin delivery with multiple daily insulin injections and continuous glucose monitoring in adults with type 1 diabetes in Japan
ABSTRACT Aim The use of automated insulin delivery systems, including the MiniMed™ 780G advanced hybrid closed‐loop system, has been shown to improve glycemic management in people with type 1 diabetes (T1D). The aim was to assess the...
-
Diagnostic model based on machine learning with multi‐feature analysis for diabetic peripheral neuropathy in type 2 diabetes: A single‐center retrospective study
ABSTRACT Objective Diabetic peripheral neuropathy (DPN) is a common and serious complication of diabetes, which imposes a significant economic burden on both society and individuals. Therefore, early identification and diagnosis are...
-
Renin-angiotensin system inhibitors and arterial stiffness in chronic kidney disease: results from the chronic renal insufficiency cohort
Journal of Human Hypertension, Published online: 31 October 2026; doi:10.1038/s41371-026-01241-7 Renin-angiotensin system inhibitors and arterial stiffness in chronic kidney disease: results from the chronic renal insufficiency cohort
- Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 12
- Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Appendices
- Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 10
- Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 11
- Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 9
- Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 8
- Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 7
- Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 6
- Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 5
- Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 4
- Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 2